Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.35 |
| ▸ | RARA | P10276 | 2/20 | 0.35 |
| ▸ | RARG | P13631 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 7/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | RXRG | P48443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17108380 | 1.00 | RARB (0.35) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL13002204 | 0.93 | RARB (0.36) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL17471827 | 0.93 | RARB (0.33) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL19560398 | 0.93 | RARB (0.33) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL21937826 | 0.92 | RARB (0.41) | RARBRARARARGHSD17B10MAPT | |
| SCHEMBL15965527 | 0.92 | RARB (0.41) | RARBRARARARGHSD17B10MAPT | |
| SCHEMBL19775611 | 0.92 | RARB (0.32) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL21564996 | 0.92 | RARB (0.37) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL12625465 | 0.92 | S1PR1 (0.35) | RARBRARARARGNPC1RAB9A | |
| SCHEMBL14226537 | 0.92 | KIF11 (0.39) | RARBRARARARGNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 438 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119555817-A | Pretreatment method for efficiently extracting trace liquid crystal monomer from water based on membrane filtration technology | 南京理工大学 | 2025-03-04 | — | — | CN | claimed |
| CN-119438433-A | Based on UiO-66-F4Method for analyzing liquid crystal monomer in indoor dust by solid phase extraction-high performance liquid chromatography | 北京工业大学 | 2025-02-14 | — | — | CN | claimed |
| WO-2023005682-A1 | METHOD FOR ANALYZING TARGETED EXPOSURE GROUP OF ENVIRONMENTAL POLLUTANTS IN PLASMA, AND USE THEREOF | 暨南大学 | 2023-02-02 | — | — | WO | claimed |
| CN-113671068-A | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof | 暨南大学 | 2021-11-19 | — | — | CN | claimed |
| CN-119555817-A | Pretreatment method for efficiently extracting trace liquid crystal monomer from water based on membrane filtration technology | 南京理工大学 | 2025-03-04 | — | — | CN | disclosed |
| EP-4317124-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-20240018081-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | DAIKIN INDUSTRIES, LTD. (JP) | 2024-01-18 | — | — | US | disclosed |
| CN-117098744-A | Method for producing organofluorine compound | 大金工业株式会社 | 2023-11-21 | — | — | CN | disclosed |
| CN-110790641-B | Method for producing compound having oxydifluoromethylene skeleton | 大金工业株式会社 | 2023-02-28 | — | — | CN | disclosed |
| WO-2023005682-A1 | METHOD FOR ANALYZING TARGETED EXPOSURE GROUP OF ENVIRONMENTAL POLLUTANTS IN PLASMA, AND USE THEREOF | 暨南大学 | 2023-02-02 | — | — | WO | disclosed |
| CN-113671068-B | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof | 暨南大学 | 2023-01-24 | — | — | CN | disclosed |
| WO-2022202888-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | ダイキン工業株式会社 | 2022-09-29 | — | — | WO | disclosed |
| US-20090051855-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | CHISSO CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20080280071-A1 | POLYMER/LIQUID CRYSTAL COMPOSITE AND LIQUID CRYSTAL ELEMENT | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2008-11-13 | — | — | US | disclosed |
| US-7399427-B2 | Mixtures comprising a multicyclic difluoromethoxy benzene compounds, a cyclohexyl-alkoxy-benzyl compounds, or hydrocarbon cyclohexyl-benzyl compounds; wide temperature range, low viscosity, optical anisotropy, dielectrics | CHISSO CORPORATION (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20080099726-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION AND CHISSO PETROCHEMICAL CORPORATION | 2008-05-01 | — | — | US | disclosed |
| US-20080083903-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2008-04-10 | — | — | US | disclosed |
| EP-1762605-A1 | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | Chisso Petrochemial Corporation (JP) | 2007-03-14 | — | — | EP | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | CHISSO PETROCHEMICAL CORPORATION (JP) | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070051919-A1 | NAPHTHALENE COMPOUND WITH TERMINAL HYDROGEN, LIQUID CRYSTAL COMPOSITION INCLUDING THE COMPOUND, AND LCD DEVICE INCLUDING THE LIQUID CRYSTAL COMPOSITION | LEF1, CFD, FOXO1 | RARB 4017/4885RARA 3694/4885RARG 4261/4885 |
| US-20240018081-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | PFAS, FBL, FLNB | RARB 861/4885RARA 1047/4885RARG 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.